| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CCCS | Common Stock | Sale | -$207 M | -18.3 M | -15.2% | $11.30 | 102 M | Jul 1, 2024 | See Notes | F1, F2, F5 |
| transaction | CCCS | Common Stock | Sale | -$6.55 M | -579 K | -15.2% | $11.30 | 3.23 M | Jul 1, 2024 | See Notes | F1, F3, F5 |
| transaction | CCCS | Common Stock | Sale | -$68.6 M | -6.08 M | -15.2% | $11.30 | 33.9 M | Jul 1, 2024 | See Notes | F1, F4, F5 |
| Id | Content |
|---|---|
| F1 | See Exhibit 99.1 for text of footnote (1). |
| F2 | See Exhibit 99.1 for text of footnote (2). |
| F3 | See Exhibit 99.1 for text of footnote (3). |
| F4 | See Exhibit 99.1 for text of footnote (4). |
| F5 | See Exhibit 99.1 for text of footnote (5). |
Christopher Egan, a Managing Partner of Advent, Eric Wei, a Managing Director of Advent, and Lauren Young, a Managing Director of Advent (collectively, the "Advent Directors"), each serve on the board of directors of the Issuer, and have been deputized to represent the Reporting Persons on the board of directors. By virtue of the Advent Directors' representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons may be deemed directors by deputization of the Issuer. The Advent Directors have filed separate Section 16 reports disclosing securities of the Issuer that they may be deemed to beneficially own for Section 16 purposes. Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated by reference.